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Female sterilisation remains an important method of family planning. Globally voluntary tubal 
sterilisation accounts for one third of contraceptive use (Rowlands & Hannaford, 2003). In 
South Africa, according to the South African Demographic Health Survey (SADHS) of 2003, 
23% of all women age 45-49 years and 18% of women aged 40-44 years had been sterilised. 
 
King Dinuzulu Hospital Complex (formerly King George V Hospital) is the primary referral 
center for elective interval laparoscopic sterilisations for women in Durban. Following the day 
procedure at King Dinuzulu Hospital Complex, women are followed up at their nearest clinics 
or hospitals. All women are subsequently seen at King Dinuzulu Hospital Complex 
approximately one year later to assess their reproductive health and satisfaction post 
procedure. 
 
Internationally, studies have been conducted to address both personal and health outcomes 
post sterilisation. However, to our knowledge, no local studies have been conducted in 
Durban, South Africa addressing women’s reproductive health and satisfaction post 
sterilisation.  
 
This has encouraged the concept of a study of this nature to be conducted. This study aimed to 
assess the reproductive health and satisfaction prospectively in a cohort of women following 
interval sterilisation in Durban. Such information would allow local health care providers to 
counsel women better who choose sterilisation as their method of contraception. This study 
would also serve as an audit of current practice and allow for improvements in service 
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delivery. This research study has identified issues in reproductive health of women undergoing 
sterilisation and has attempted to recommend strategies to improve women’s reproductive 
health and satisfaction post sterilisation. These recommendations can thus be extended to 


























A prospective study was conducted to determine reproductive health, women’s use of the 
health services and overall satisfaction following interval laparoscopic sterilisation at King 
Dinuzulu Hospital, South Africa. 
 
METHODS 
The study population included women who underwent interval tubal ligation from 1 August 
2012 to 30 April 2013 with follow up one year after the procedure. Data were captured and 
analysed using SPSS version 19.0. 
 
RESULTS  
The study cohort consisted of 225 women who returned for follow up one year post 
sterilisation. Of the cohort, 97% of women (n=220) were satisfied with the procedure. 
Complications were minimal with 1 procedure (0.4%) requiring conversion to laparotomy due 
to haemorrhage and 3 procedures (1.3%) complicated by uterine/cervical perforations during 
laparoscopy. The rate of regret was low (0.8%) and mainly due to change in partners.  There 
were no failures at one year follow up.  
 
Following sterilisation, sexually transmitted infections were increased only in women with a 
past history of infection pre-sterilisation (OR 6.7; 95% CI (2.2–20.9); p=0.002). There was no 
significant risk of HIV acquisition post sterilisation. 
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In women who had not used hormonal contraception or used barrier methods pre-sterilisation, 
no change in frequency, volume of menstrual bleeding or dysmenorrhoea post sterilisation was 
found. There was an increase in duration and amount of menstrual bleeding and 
dysmenorrhoea post sterilisation among previous combined oral contraceptive users. Among 
women on injectable contraception who were amenorrhoeic pre-sterilisation, 73.8% reported 
return to regular menses and 26.2% reported abnormal uterine bleeding post sterilisation. 
Among injectable contraceptive users with regular menses or spotting pre-sterilisation, 71.4% 




Interval tubal sterilisation is a safe and effective procedure.  The procedure is associated with 
high patient satisfaction, low incidence of regret and minimal complications. 
 
In women undergoing interval tubal sterilisation, the risk of sexually transmitted infections is 
only increased in those women with a prior history. Menstrual abnormalities post sterilisation 









CHAPTER 1: ORIENTATION AND LITERATURE REVIEW 
 
1.1 INTRODUCTION AND BACKGROUND TO THE STUDY 
 
This chapter provides the background detail to the research study. It commences by focusing 
on the introductory background to the problem investigated by reviewing both international 
and local literature and related research conducted followed by the legislative frameworks on 
health practices in South Africa. 
 
Tubal sterilisation is a safe, permanent and effective contraceptive method used worldwide 
(Rowlands & Hannaford, 2003). Approaches for tubal sterilisation include laparotomy, mini-
laparotomy, laparoscopic and hysteroscopic techniques (e.g. Essure micro insert). Techniques 
of sterilisation include partial salpingectomy, unipolar or bipolar coagulation, silicone rubber 
band or clip application. Sterilisation may be performed in relation to pregnancy (after 
abortion, caesarean section or normal vaginal delivery) or remote from pregnancy (interval 
sterilisation) (Peterson et al., 2008). 
 
The surgical methods for tubal ligation include partial salpingectomy (via the Pomeroy 
technique or “Modified” Pomeroy technique, Parkland method or Irving method). 
Laparoscopic mechanical methods include the Yoon ring (composed of silicone or rubber) and 





A Cochrane review by Lawrie et al (2011) included randomized controlled trials and 
compared the different techniques of tubal sterilisation. This review compared morbidity, 
technical difficulties and failure rates associated with the various techniques. The overall 
findings of the meta-analyses were that electrocoagulation is associated with less morbidity 
and pain that Pomeroy and ring methods. Minor morbidity was higher in the ring versus the 
clip groups. Less technical difficulties were found in the clip group compared to the ring group 
with no difference in failure rates between these two groups. The Pomeroy technique was 
associated with higher major morbidity and postoperative pain when compared to 
electrocoagulation technique. The tubal ring group was associated with greater postoperative 
pain than the electrocautery group. No pregnancies were reported in either group. One 
pregnancy was reported after 1 year with the Pomeroy technique and no pregnancies found 
with the Filshie clip. Comparing the Hulka to the Filshie clip, no differences were found 
between these two devices. 
 
Tubal sterilisation is a highly effective contraceptive with a Pearl index of 0.18 (Von Mering 
et al., 2003). At King Dinuzulu Hospital Complex (formerly King George V Hospital), 














Globally statistics show that the age of sterilisation is inversely related to the prevalence of 
sterilisation in the area. In high sterilisation prevalence settings such as Brazil, Dominican 
Republic and El Salvador the mean age of sterilisation is <29 years with overall prevalence of 
sterilisation being near 25%. The mean age of sterilisation in low prevalence (prevalence 
<10%) countries such as Egypt, Ghana, Indonesia and Peru is 32 years. The number of living 
children of women presenting for sterilisation varies between countries. In the United States 
and China the majority of sterilisation users have 0-2 living children while in North Africa and 
Sub-Saharan Africa the majority of users have 5 or more living children (Henderson & 
Escandon, 2002). 
 
Gender differences regarding sterilisation have been studied in both developed and developing 
countries. Rowlands and Hannaford (2003) found no significant differences in incidence 
between men and women having sterilisation in the United Kingdom over an eight year period 
(1992-1999). They further demonstrated a 30% decline in female sterilisation during their 
study period in the United Kingdom.  In contrast in a third world setting, Gupta et al (1996) 
demonstrated that female sterilisation had grown in popularity in India with an increase in the 





1.2. 2 Durban, KwaZulu-Natal, South Africa 
 
The most common contraception method in South Africa presently is progestogen injectable 
contraception being utilised by up to 56% of sexually active women according to the South 
African Demographic and Health Survey (SADHS) of 2003.  Female sterilisation accounts for 
14% of contraceptive use among sexually active women. In 2003, 23% of all women aged 45-
49 and 18% of all women aged 40-44 years had been sterilised. Compared to previous data in 
1998, there is an increase in the age of timing of sterilisation implying women are choosing to 
be sterilised later in their reproductive lives. In 1998, 64% of women who had been sterilised 
had undergone the procedure by the age of 34 years compared to 61% in the 2003 survey. The 
median age of sterilisation of just over 32 years has not changed between surveys. 
 
A retrospective study of tubal sterilisation at King Dinuzulu Hospital (formerly King George 
V Hospital) from the period 1989–1991 examined the demographic characteristics of women 
undergoing tubal sterilisation at the health facility. The population in this study was 67.57% 
African women and 32.44% Asian women as evidence of the population representative in 
Durban. The mean age of women was 31.30 years and 34.5 years among Asian and African 
women respectively. Ninety two percent of Asian and 41.2% of African women were married. 
The mean parity among groups was 2.96 among Asian women and 5 for African women 







1.3 National Contraception Clinical Guidelines and Consent, South Africa 
 
In South Africa, there has been an increase in the availability and free supply in the public 
sector of long acting reversible contraception. The National Contraception Clinical Guidelines 
encourage health professionals to counsel women adequately on all available contraceptive 
methods to ensure autonomy of women in the decision making process. Furthermore, avoiding 
coercion to accept sterilisation in pre-sterilisation counselling has been enforced heavily by the 
Department of Health, South Africa. Recommendations include adequate counselling of 
women on long acting contraceptive methods with similar efficacy (subdermal implants, 
copper intrauterine devices and levonorgestrel intrauterine devices) as well as male 
sterilisation before recommending female sterilisation (National Contraception Clinical 
Guidelines, 2012). 
 
In South Africa, the Sterilisation Act 44 of 1998 (Section 2) prohibits the “sterilisation of 
women without their informed consent”. The Act stipulates that “all women must fully 
understand the sterilisation procedure, risks, and the consequences thereof, before they are 
able to give informed consent” (National Contraception Clinical Guidelines, 2012). The 
Sterilisation Amendment Act (Act No 3 of 2005) makes provision for women not considered 
competent to make an informed decision and consent to surgery.  Informed consent as set out 
by the bill is a process, and a signature on a consent form is not sufficient. “A person giving 
consent to sterilisation needs to be in a physical and psychological state to understand the 
information, and make the decision without feeling pressured” (National Contraception 




The National Contraception Clinical Guidelines emphasises that human immunodeficiency 
virus (HIV) status should not be a reason to recommend sterilisation and that both HIV 
positive women and HIV negative women should be afforded the same legal protection and 
rights. The national guidelines also emphasises that women must be counselled that 
sterilisation offers no protection from HIV and sexually transmitted infections (STIs). All 
women must be counselled on condom use post sterilisation (National Contraception Clinical 
Guidelines, 2012). 
 
These guidelines in South Africa help to empower women to make an informed decision 
regarding sterilisation. The guidelines are set in place to relieve women’s concerns regarding 
the sterilisation procedure and to prevent complications after the procedure such as post 
sterilisation regret (National Contraception Clinical Guidelines, 2012). 
 
1.4 IMMEDIATE COMPLICATIONS 
 
In the United States of America deaths post sterilisation are rare. Assessment of sterilisations 
performed in hospitals from 1979-1980 revealed a case fatality of 1-2 per 100,000 procedures. 
Complications of general anaesthesia were the leading cause followed by sepsis and 
haemorrhage (Peterson et al., 2008). 
 
Morbidity following sterilisation is largely dependent on the surgical approach and method of 
tubal ligation employed. Data from the United States of America showed infection (1% of 
cases), minor or major bleeding (up to 1% of cases) and anaesthetic events (up to 2% of cases) 
have been reported (Bartz & Greenburg, 2008). Complications of mini-laparotomy typically 
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include minor wound infection, longer operating time, longer postoperative convalescence 
time and greater postoperative pain. Laparoscopic complications include thermal bowel injury, 
viscus perforations and life-threatening haemorrhage (Peterson et al., 2008). 
 
At King Dinuzulu Hospital (formerly King George V Hospital), a retrospective analysis 
revealed low immediate complication rates. 5360 procedures were performed during a 3 year 
period (1989–1991) with no deaths or serious injuries noted. Of these procedures, two 
laparotomies were performed for haemorrhage (0.37 per 1000 laparoscopies) and no organ or 
bowel injury was reported (Green-Thompson et al., 1993). 
 
1.5 DELAYED COMPLICATIONS AND REPRODUCTIVE HEALTH 
 
1.5.1 Pregnancy  
 
Pregnancies secondary to sterilisation failures have been reported in the literature with cases 
occurring years after the sterilisation procedure. In the first year following sterilisation, 
pregnancy rates among women are documented as up to 0.5% and this rate is similar and 
comparable to pregnancy rates for women using LARC (long-acting hormonal contraception) 
such as the intrauterine device or subdermal implant. Sterilisation failure may be due to the 
result of conception occurring prior to the sterilisation procedure, incomplete tubal occlusion 





Tubal sterilisation is an effective contraceptive method. The efficacy rates vary dependant on 
the method of sterilisation employed as well as the women’s age, race and ethnicity. Data 
from the U.S Collaborative Review of Sterilization (CREST) study revealed a 10-year 
probability of pregnancy following tubal ligation being 18.5 pregnancies per 1000 procedures 
performed (Peterson et al., 1996). 
 
Pregnancy rates were highest among women sterilised via laparoscopic clip insertion (36.5 
pregnancies per 1000 procedures) with lowest rates following laparoscopic unipolar 
coagulation and postpartum partial salpingectomy (7.5 pregnancies per 1000 procedures). 
Sterilisation failure rates are generally higher in women sterilised at younger ages due to 
increased fertility in these women (Peterson et al., 1996).  
 
Luteal phase pregnancy rates range from 2-3 per 1,000 sterilisation procedures.  This 
complication can be prevented by performing sterilisation in the follicular phase of the 
menstrual cycle. The likelihood of ectopic pregnancy is higher when pregnancy does occur 
following sterilisation. However, the overall risk of ectopic pregnancy in women post 
sterilisation is lower than women using no contraception and similar in women using barrier or 
oral contraceptives. The CREST study revealed a 10 year probability of an ectopic pregnancy 
of 7.3 ectopic pregnancies per 1000 sterilisation procedures and ectopic pregnancy accounted 







1.5.2 Menstrual changes 
 
It has been hypothesised since 1951 that sterilisation might increase a woman’s risk of 
abnormal uterine bleeding (post tubal ligation syndrome–risk of heavy bleeding and 
intermenstrual bleeding). This was thought to be due to sterilisation adversely affecting 
ovarian function (by disrupting ovarian blood flow). However, laboratory findings found no 
consistent abnormalities in ovarian function post sterilisation (Peterson et al., 2008). Wilcox et 
al (1992) found an increased risk of menstrual abnormalities up to 5 years post sterilisation, 
while Peterson et al (2000) found women to report decreases in number of days and amount of 
bleeding, dysmenorrhoea and increase in cycle irregularity. Controlled for previous 
contraceptive use, further studies have found no direct influence of sterilisation on menstrual 
patterns (Harlow et al., 2002; Westhoff, 2000; Rulin et al., 1993). 
 
Wilcox et al (1992) found that sterilisation at a younger age leads to more menstrual 
abnormalities than sterilisation at older ages. Initial data from the U.S Collaborative Review of 
Sterilization Study revealed menstrual abnormalities were more likely during the fifth year 
than the second year post sterilisation. Five years after sterilisation, 35% of participants 
reported higher levels of menstrual pain, 49% reported very heavy flow and 10% reported 
spotting between periods. In women interviewed one year after sterilisation, no menstrual 
function changes were noted. This initial data, however, had no comparisons and did not 
account for ageing.  
 
In 2000, Peterson and colleagues studied menstrual function before and after sterilisation 
among women who underwent tubal sterilisation and compared them to women whose 
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partners underwent vasectomy. The study used data from the U.S Collaborative Review of 
Sterilization Study. The study consisted of 9514 women who had undergone sterilisation and 
573 women whose partners underwent vasectomy. These women were followed up for 5 years 
telephonically and asked about menstrual changes. The results revealed that women who 
underwent sterilisation were no more likely than those who had not undergone sterilisation to 
report persistent changes in their menstrual bleeding or length of their menstrual cycle. 
Women who underwent sterilisation were more likely to have decreases in the number of days 
of bleeding, volume of menstrual bleeding and dysmenorrhoea and were more likely to have 




It is a common belief that sterilisation increases the risk of women having a hysterectomy. The 
CREST study found a 5 year cumulative probability of hysterectomy of 8.4% compared with 
1.8% in non-sterilised women (Hillis et al., 1998).  It has, however been demonstrated that 
women who are sterilised are at no increased risk of needing a hysterectomy but rather a 
hysterectomy is more readily offered to women for gynaecological complaints (i.e. menstrual 
disorders) (Bartz & Greenburg,  2008). 
 
The term post tubal sterilisation syndrome has been used to include abnormal menstrual 
bleeding, dysmenorrhoea, premenstrual distress and menopausal symptoms experienced by 
women post sterilisation. The syndrome is hypothesised to be caused by altered blood 
circulation in and around the fallopian tubes and ovaries, pressure on associated nerves and 
intrapelvic adhesions (Moradan et al., 2012). 
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Moradan et al (2012) compared the incidence of hysterectomy for bleeding disorders among 
sterilised women with the incidence of hysterectomy for bleeding disorders among non-
sterilised women. Statistical analyses showed that there were no significant differences 
between two groups (RR=0.85; p=0.418). The results of this study showed that previous tubal 
sterilisation is not a risk factor for undergoing hysterectomy because of abnormal uterine 
bleeding.  
 
Mackenzie et al (2010) demonstrated that 6% of women following tubal sterilisation undergo 
hysterectomy or endometrial ablation because of abnormal uterine bleeding. Analysis, 
however, showed that tubal sterilisation is not an independent risk factor for hysterectomy due 
to abnormal uterine bleeding. Ozerkan et al (2010) reported that some kind of menstrual 
pattern changes happened in 7.6% of cases after tubal sterilisation, however, these changes 
were mild. Thus consistently, these studies have found that there is no increased risk of 
requiring a hysterectomy for abnormal uterine bleeding post sterilisation. 
 
With regard to menopause and menopausal age, Nichols et al (2013) found that women who 
had a tubal ligation were more likely to report hot flashes and other symptoms of menopause 
(poor sleep, night sweats, irritability and depression) compared to women who did not 
previously have a tubal ligation. However, no association was observed between tubal ligation 
and actual menopausal age. A study of 3650 postmenopausal women in the United Kingdom 
reported a 38% increase in the odds of menopause before the age of 49 years among women 
who had a tubal ligation (Pokoradi et al., 2011). However, other studies have not confirmed 




1.5.4 Sexual function post sterilisation 
 
Women often report little or no change in sexual interest and pleasure following tubal 
sterilisation. In those women who do report change, the majority report favorable effects of 
sterilisation on sexual interest and pleasure (Costello et al., 2002; Cooper et al., 1982; Bean et 
al., 1980; Richards et al., 1991; Smith et al., 1994). 
 
Costello et al (2002), as part of the working group for the U.S Collaborative Review of 
Sterilization Study (which represents the largest United States cohort of women undergoing 
tubal sterilisation), undertook a cohort study to assess sexual function post sterilisation. The 
study population comprised 4 576 women who were followed up two years post procedure to 
assess sexual function post tubal sterilisation. Of the cohort, 80% of women reported no 
change in their sexual interest or pleasure after interval tubal sterilisation. In those women 
with change in sexual function, positive change was reported up to 15 times more often than 
negative change. Women who experienced post sterilisation regret were identified as those at 
risk for decreased sexual interest and pleasure post sterilisation. 
 
In contrast, Gulum et al (2010)  in a smaller series, found higher rates of female sexual 
dysfunction among women who had previously had tubal sterilisation and this finding was 









Regret following sterilisation can be prevented by careful patient selection and patient 
counselling pre-procedure. Data from the U.S Collaborative Review of Sterilization Study 
revealed the cumulative probability of expressing regret following sterilisation was 12.7% 
(Hillis et al., 1999).  
 
Young age (<30) at the time of sterilisation is one of the most important predictors of regret. 
Another important predictor of regret is the timing of sterilisation with regret rates higher with 
sterilisation done during a caesarean section or immediately postpartum rather than interval 
sterilisation. The greater the interval from an obstetric event, the lower the incidence of regret 
reported by patients (Rosenfeld et al., 1998).  
 
Regret following sterilisation may also be related to changes in the patient’s situations or 












1.5.6. Health benefits 
 
Tubal sterilisation has been documented in the literature as being protective against the 
development of ovarian cancer. The Nurse’s Health Study found a 67% risk reduction of 
epithelial cancer development in sterilised versus non-sterilised women. Women who have 
BRCA 1 gene mutation have an up to 60% reduction in risk of ovarian cancer following 
sterilisation (Hankinson et al., 1993).  
 
A significant additional health benefit of sterilisation is the reduction of pelvic inflammatory 
disease following sterilisation. Sterilisation does not protect against sexually transmitted 
disease, however, appears to protect against pelvic ascent of such infection (Bartz & 
Greenburg, 2008). 
 
1.5.7. HIV and sterilisation 
 
Up to 80% of the world’s 15.5 million HIV-infected women reside in Sub-Saharan Africa. 
Each year, these women experience over 1.4 million pregnancies of which 50-84% are 
unintended (Kaida et al., 2010). 
 
The history of ART (antiretroviral treatment) in South Africa began in 2004 with the 
introduction of ART into the public sector. In 2009, President Jacob Zuma announced new key 
interventions to improve ART access to special groups (all HIV positive infants, pregnant 
women, those with TB and HIV co-infection and those patients with CD4 counts less than or 
equal to 350 cells/μl). This intervention was implemented to decrease the disease burden. 
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Furthermore, the implementation was made to reduce maternal and child mortality as well as 
to improve life expectancy. This resulted in a widespread increase in the uptake of use of these 
drugs (Kaida et al., 2010). In 2013, the fixed-dose combination pill (FDC) was introduced to 
improve both adherence and retention. In July 2014, coverage of ART was expanded to 
include those individuals with a CD4 count  ≤500 cells/μl and the Prevention of mother to 
child transmission (PMTCT) programme was expanded to adopt the B+ approach, which 
entitles every pregnant and breastfeeding women to lifelong ART regardless of CD4 count or 
clinical staging. This policy was brought into effect in January 2015 (Department of Health, 
South Africa, 2014).  
 
The widespread availability and uptake of ART may reflect contraceptive knowledge as well 
as the utilisation of contraception among HIV positive women. In the pre ART era, 
contraceptive choices, particularly long acting and permanent methods, remained poorly 
understood by HIV positive women. In a study comparing contraceptive choices among HIV 
positive and HIV negative women in Cape Town, South Africa, it was found that the majority 
of pregnancies were unplanned (61.6% HIV positive and 63.2% HIV negative). Amongst both 
groups of women short term contraceptives were most commonly used with only 6.44% of all 
women using long acting and permanent methods. Poor knowledge of long acting and 
permanent methods of contraception was the most common factor in both groups of women 
contributing to the poor uptake of these methods (Crede et al., 1995). 
 
Post ART availability, data regarding contraception knowledge as well as usage appears to be 
more promising. In a cross sectional survey in Soweto, South Africa 2010, 78% of women 
reported using contraception, with significant variation by HIV status. Contraceptive use was 
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86% among ART users, 82% among HIV positive women not on ART, and 69% among HIV-
negative women (p=0.0001). HIV positive women receiving ART were more likely to use 
contraception than HIV negative women (OR=2.40). Among HIV positive women, ART users 
were non-significantly more likely to use contraception compared with non-ART users 
(OR=1.55). Similar patterns were observed for barrier (primarily male condoms), permanent, 
and dual protection contraceptive methods. Among HIV positive patients, only 39% reported 
consistent condom use (with or without another contraceptive method). This prevalence is 
comparable to condom use rates reported in South Africa overall.  Overall, 7% of women used 
permanent methods (hysterectomy and/or female sterilisation) with non-significant, small 
differences by HIV status and HAART use (Kaida et al., 2010). 
 
Internationally, it has been demonstrated that HIV positive women are more likely than HIV 
negative women to undergo tubal sterilisation as a method of contraception (Lindsay et al., 
1995). Postoperative complications would depend on the patient profile and immune status. 
Devito and Robinson (1995) had demonstrated asymptomatic HIV has minimal effect on the  
outcome of elective gynaecological surgery with complications among HIV infected and non-











1.5.8. Sexually transmitted infections and sterilisation 
 
The prevalence of sexually transmitted infections (STIs) in Durban, South Africa remains 
extremely high with a disproportionate burden amongst women.  STIs occur in up to 13% of 
women with an incidence rate of up to 20 per 100 women years. The sequelae include 
facilitated HIV transmission and acquisition, pelvic inflammatory disease and chronic pelvic 
pain (Naidoo et al., 2014). 
 
Literature regarding the influence of sterilisation on the risk of STIs suggests that high risk 
women (multiple partners and HIV positive) are at an increased risk of STIs due to low rates 
of condom use post sterilisation (Pruitt et al., 2010).  Contrary to this finding, Sangi-
Haghpeykar et al (1998), reported women at high risk of contracting STIs (past history or 
multiple partners) are significantly more likely to plan condom use post sterilisation with 
insignificant risk of exposure to disease post procedure. 
 
1.5.9. Reproductive health and sterilisation 
 
Reproductive health, as outlined by the World Health Organisation (WHO), addresses the 
“reproductive processes, system and functions at all stages of life”. This involves the “right of 
both men and women to be informed of and to have access to safe, effective, affordable and 
acceptable methods of fertility regulation of their choice and the right of access to appropriate 




Internationally, studies have been conducted to address reproductive health after sterilisation 
as outlined above, however, there remains a lack of local evidence to guide current practice 
and identify issues in reproductive health of women undergoing sterilisation. This has 





























This chapter outlines the significance of the study. In other words, the foundation of the study 
is laid out clearly. It highlights the purpose of the study, the research questions, the 
methodology and the statistical analysis. 
 
2.2 Purpose of the Study 
 
A prospective study was conducted to determine reproductive health, women’s use of the 
health services and overall satisfaction following interval laparoscopic sterilisation at King 
Dinuzulu Hospital Complex (formerly known as King George V Hospital), in the Province of 




The following specific objectives were pursued: 
1. To determine the demographic profile of women having interval sterilization at King 
Dinuzulu Hospital. 
2. To determine reasons women choose sterilisation as a contraceptive method.  
3. To assess overall satisfaction one year post the sterilisation procedure. 
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4. To determine the prevalence of and reasons for regret post sterilisation. 
5. To determine whether sterilisation influences the prevalence of   
gynaecological disorders in women e.g. menstrual abnormalities, sexually transmitted 
infections and pelvic inflammatory disease. 
6. To assess if women are at a greater risk of HIV acquisition post tubal ligation. 
 
2.4 Research context and methodology 
 
This was a prospective cohort study of women who underwent sterilisation with regard to their 
reproductive health and overall satisfaction with the procedure one year post sterilisation. 
King Dinuzulu Hospital Complex (formerly King George V Hospital) remains the primary 
referral centre in Durban, KwaZulu-Natal, South Africa for elective interval laparoscopic 
sterilisation. King Dinuzulu Hospital Complex (formerly King George V Hospital) is situated 
in Springfield in Ward 25 of the eThekwini health district. This public hospital complex offers 
the following specialised services: 
 Multi-drug resistant (MDR) and complicated TB 
 Orthopaedic spinal surgery, psychiatric, family planning (sterilisation) 
 
Women who are referred to King Dinuzulu Hospital Complex (formerly King George V 
Hospital) for sterilisation routinely are offered a gynaecological consultation, HIV test, RPR 
test and Pap smear (if indicated as per national screening program). These women are then 
routinely followed up one year post sterilisation with a gynaecological consultation, HIV test, 
RPR and Pap smear (if symptomatic or as per national screening program). 
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The proposed study would have included all women who presented for sterilisation from 1 
June 2012 to 28 February 2013. Their follow up at one year post sterilisation i.e. 1 June 2013 
to 28 February 2014 would have been included in the study. However, ethical approval had 
not been granted by this time, hence commencement of the study was subsequently delayed. 
 
Full ethical approval of the study was granted on the 25 July 2013, hence the study period and 
population group were changed with the approval of the University of KwaZulu-Natal Ethical 
Board.  
 
The study population included all women who presented to King Dinuzulu Hospital Complex 
from the 1 August 2012 to 30 April 2013. These women were routinely offered a 
gynaecological consultation, HIV test, RPR test and Pap smear (as per national screening 
program). The information of this consultation was subsequently recorded in women’s records 
as per routine pre-sterilisation data sheet (Appendix 1). 
 
These women subsequently underwent the tubal ligation procedure. This procedure is an 
outpatient procedure at King Dinuzulu Hospital Complex.  The procedures were performed 
under local anaesthetic and conscious sedation. These procedures were performed by a 
registrar under the supervision of the consultant in charge of the unit (the supervisor of the 
study). Women were positioned and draped in theatre following the administration of 1-2 
milligram (mg) of midazolam hydrochloride and 1-2 mg/kg of fentanyl citrate. The procedures 
were performed via a two port laparoscopic technique (sub-umbilical and suprapubic ports) 
using Filshie clips applied to both fallopian tubes.  Women were reviewed and discharged post 
operatively the same day. All significant intra-operative findings were recorded in women’s 
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charts. All women received a 25 mg diclofenac suppository per rectum during the procedure 
(provided there were no contra-indications) and a 3 day nocte course of the suppository and 1 
week paracetamol course (1 gram 6 hourly) for analgesia. On discharge all women were given 
a one year follow up appointment and reminder form.  
 
Women were then followed up one year post sterilisation i.e. 1 August 2013–30 April 2014 on 
an outpatient basis. They were offered a gynaecological consultation, HIV test, RPR test and 
Pap smear (as per national screening program). These data were recorded in post sterilisation 
sheets with consent from the women to utilise this information for study purposes (Appendix 
2). 
 
Women who failed to return for follow up consultation were contacted telephonically to return 
for their follow up 12-18 months post procedure. These women were subsequently followed 
up till ethical approval expired i.e. 25 July 2014. Women who returned for follow up one year 
post sterilisation for review and who consented to utilise their information for the study were 
included in the study cohort. 
 
Data were collected according to the attached data sheet (Appendix 1: Data sheet: Pre-
sterilisation, Appendix 2: Data sheet: Post sterilisation). These data were collected from 
interview and charts review. Registrars in family planning were trained on the use of the data 
sheet and the conduct of the interview. These interviews were conducted by registrars and the 
consultant in charge of the unit (the supervisor of the study). All questionnaires were 
completed as per standard layout from interview and examination of women. Confidentiality 
was ensured in that these interviews and examinations of women were conducted in a private 
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room. Following the interviews, patient names were blocked off the data sheet with a black 
pen and a data number allocated to the data sheet by the supervisor of the study. These data 
were then placed in a lock-in cupboard for only the research team to access. The data were 
kept confidentially and strictly for the purpose of the study at hand. 
 
Both quantitative and qualitative research designs were used in gathering data. Within the 
qualitative approach; the use of document analysis, observations and semi-structured 
interviews were utilised with the intention of obtaining in-depth qualitative information. The 
quantitative approach was utilised by the administration of questionnaires. This strategy was 
used to gather numerical data from the study population. 
 
2.5 Statistical analysis  
 
Results were summarised by frequencies and percentages (categorical variables) and means, 
medians, standard deviation or percentiles (numerical variables) as appropriate. Normal 
distributed data were analysed using a paired samples Students t-test when comparing two 
groups. The Wilcoxon sign rank test was used for comparison of the pre and post sterilisation 
differences on certain variables like menstrual abnormalities. Pearson’s chi-square or Fischer’s 
Exact test were utilised to identify trends between categorical data variables as appropriate.  
Data were captured and analysed using the Statistical Package for Social Sciences (SPSS) 







Selection bias was encountered in that only women who were willing and able to present 
themselves one year post sterilisation were included in the study. A further limitation was that 
information regarding menstrual patterns, STIs and sexual behaviours were obtained from the 
women’s history and from subjective observations with no objective methods of measurement. 
The study follow up was over a one year time period while longer follow up may have been 
more beneficial to add value to the results. 
 
Both pre and post sterilisation data sheets categorised Marital Status as either “single”, 
“married”, “divorced” and “widowed”. A limitation to this categorisation is that women may 
have claimed to be “married” when either in a casual relationship with a partner or in a legally 
or formally recognised union. A further limitation to our study was that we did not ask women 
about the nature of their marital relationship (i.e. if they suspected their partner to be 












DATA ANALYSIS AND INTERPRETATION 
3.1 Introduction  
 
Chapter 3 provides a detailed analysis of data collected through various instruments such as 
questionnaires and documents. Both quantitative and qualitative research methods were 
employed in the study. Both figures and tables are designed to illustrate the research findings 
based on the data collected. The detailed interpretation and analysis are directly linked to the 
research questions and purpose of the study as encapsulated in chapter two.   
 
3.2 Sample size and sampling techniques 
 
A total of 337 women underwent tubal sterilisation at King Dinuzulu Hospital Complex from 
1 August 2012 to 30 April 2013. Of these 337 women, 127 returned for their one year follow 
up appointment. The remaining women were telephonically contacted to remind them to 
return for their appointments. Their reasons for not attending their follow up included: 
forgotten appointment, no reason to return as had no medical complaints, financial constraints 
as well as relocation. Of the remaining 210 women who were contacted to return for follow 
up, 98 returned for their follow up with the remaining women being unreachable 
telephonically (voicemail, incorrect number) or being unable to return due to work constraints, 
financial difficulties, relocation or family commitments. The total number of women who did 




3.3 Data gathering and techniques 
 
Data were collected by means of questionnaires (Appendix 1: Data sheet: Pre-sterilisation) 
and (Appendix 2: Data sheet: Post sterilisation).  These questionnaires were administered 
by registrars training in family planning and the consultant in charge of the unit (the 
supervisor of the study). Registrars were supervised by the above mentioned consultant on the 
administration of the questionnaires and entry of data into data sheets based on responses from 
women and examination findings. Quantitative data were collected directly from the responses 
on the questionnaires. Qualitative data were collected from the open ended questions in the 
data sheets. These included: (Appendix 1: Data sheet: Pre-sterilisation) “current 
medications”, “previous operations”, “gynaecological problems pre-sterilisation” and 
“treatment sought”. In Appendix 2: Data sheet: Post sterilisation, open ended questions 
included: “gynaecological complaints post sterilisation”, “hospitalisation and treatment 
sought” and “reasons for regret” as expressed by women. These responses were further 
categorised by similarity and analysed accordingly.  Before administering the questionnaires, 
informed consent was obtained from women with the assurance of confidentiality written in 
both English and in Zulu (Appendix 3 and Appendix 4). In addition to consent from women, 
a further letter was written to women outlining the purpose and significance of the research 
study [Appendix 5 (English) and Appendix 6 (Zulu)]. Data were collected and computed 
into Excel and SPSS spreadsheets by myself. This data was then crosschecked and analysed 
by the statistician. 
 
As with all research, permission had to be granted by the institution (King Dinuzulu Hospital 
Complex), to conduct this research study at their premises and have access to the women’s 
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files. This consent was granted by the Medical Manager (Appendix 7). The study needed to 
be registered at the Postgraduate Office, Department of Obstetrics and Gynaecology, School 
of Clinical Medicine at the University of KwaZulu-Natal, Durban. This was duly done 
(Appendix 8). Finally, ethical clearance was obtained from the Biomedical Research Ethics 
Committee of the University of KwaZulu-Natal (Appendix 9). 
 
3.4 Analysis and interpretation of data collected 
 
3.4.1 Demographic data 
 
Of the 225 women who returned for follow up, 156 women (69.3%) were married, 64 (28.4%) 
were single, 4 divorced (1.8%) and 1 widowed (0.4%) (Figure 1). The mean age of women 
was 35 years with a range of 26 years and maximum age of 42 years (SD 4.26) (Table 1). Of 
those women who were married (or in a monogamous relationship), the mean husband’s age 
was 39 years with a range of 27–56 years (SD 5.55). 
 
Table 1: Demographic characteristics of study cohort (mean ± SD) 
 
Age 35 ± 4.26 
Partner’s age 39 ± 5.55 
Parity 3 ± 1  
Haemoglobin 12.4 ±6.19 








All women were parous. The majority of women had at least 2 or more children (99.6%) 








Table 2: Parity of women 
 
Parity Frequency % of Cohort 
 1.00 1 0.4 
2.00 70 31.1 
3.00 82 36.4 
4.00 49 21.8 
5.00 20 8.9 
6.00 2 0.9 
8.00 1 0.4 
Total 225 100.0 
 
 
The number of living children women had were: 1 (n=6; 2.7%), 2 (n=66; 29.3%), 3 (n=86; 
38.2%), 4 (n=49; 21%), 5 (n=15; 6.7%), 6 (n=2; 0.9%) and 8 (n=1; 0.4%) respectively.  The 
mean age of the youngest child was 3.6 years (SD 4.21) with a range of 6 weeks to 21 years. 
Of the 225 women, 8 (3.6%) had previous miscarriages. Of these women, 6 women (2.7%) 
had 1 previous miscarriage and 2 women (0.9%) had 2 previous miscarriages. 
 
The majority of women were Black (n=135; 60%) with the remaining study population being 





Figure 2: Race of study population 
 
 
The mean BMI of women was 33.3 kg/m
2 
with a range of 17–55 (SD 7.42).  The mean ward 
haemoglobin of women was 12.4 g/dl with a range of 7-16 (SD 6.19).  
 
The majority of women had received secondary school education 163 (72.4%) with 16 women 
(7.1%) receiving only primary school education, 45 women (20%) receiving post-secondary 
school education and 1 women (0.4%) receiving no formal school education.  Of the total 225 
women, 105 (46.7%) were employed and 120 (53.3%) were unemployed. The majority of 
women had a family income of <R5000 a month (48.9%), with 30.7% of women having a 
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family income of between R5000-R10000 and 20.4% of women having a family income of 
>R10000 a month as illustrated in Table 3. 
 
Table 3: Family income per month 
 
Family Income Frequency % of Cohort 
Rands <5 000 110 48.9 
=5 000-10 000 69 30.7 
>10 000 46 20.4 
Total 225 100.0 
 
3.5 General health 
 
Of the 225 women, 169 were HIV negative (75%). Of the 56 women (25%) who were HIV 
positive, 38 (67.9%) were on ART and 18 (32.1%) were not on treatment due to CD4 counts  
>350 cells/μl. 
 
All 225 women tested RPR negative pre-sterilisation. The majority of women were previously 
well with no co-morbidities: 191 women (84.9%). The co-morbidities of the remaining women 
included diabetes mellitus (n=3; 1.3%), hypertension (n=15; 6.7%), asthma (n=3; 1.3%) and 
other co-morbidities including epilepsy, hypothyroidism, depression, tuberculosis, 




Figure 3: Medical history and co-morbidities 
 
 
A total of 47 women (20.9%) had previous abdominal surgical procedures. These procedures 
included one previous caesarian section (n=25; 11.1%), two previous caesarian sections  
(n=12; 5.3%), three previous caesarian sections (n=1; 0.4 %), previous laparotomy for ectopic 
pregnancy (n=3; 1.3%), previous ovarian cystectomy (n=2; 0.9%), previous unsuccessful tubal 







3.6 Reproductive health pre-sterilisation 
 
Of the cohort of 225 women, 206 women (91.6%) had normal Pap smears pre-sterilisation 
with 2 women (0.9%) with LSIL, 4 with HSIL on Pap smear (1.8%) and 1 woman (0.4%) with 
ASCUS on Pap smear. Twelve women (5.3%) had no recorded Pap smear pre-sterilisation. 
The women with normal Pap smears were advised about repeat smears as per national 
screening program. Those women with LSIL and ASCUS were counselled on repeat smears in 
6 months. Of the 4 women with HSIL on Pap smear, 3 were HIV positive and 1 woman HIV 
negative. Two women had colposcopy and LLETZ procedures performed and 2 women were 
referred to their base hospitals for colposcopy and LLETZ procedures. 
 
The majority of women were on injectable contraception [norethisterone enanthate (NET-EN) 
or depot medroxyprogesterone acetate (DMPA)] [n=149; (66.2%)], with the remaining 
participants utilising combined oral contraception (COC) [n=52; (23.1 %)], barrier methods 
[n=11; (4.9%)] or no contraception [n=13; (5.8 %)]. Of the cohort, 15.5% (n=35) of women 
used dual contraception.  Of 212 current contraceptive users, 119 women (56.1%) had used 
their current method for less than 2 years, 64 women (36.2%) used their method for 2-5 years 
and 29 (13.7%) used their method for more than 5 years. Ninety two of the contraceptive users 
(43.4%) had used their method continuously and 120 women (56.6%) had used their current 
method interruptedly. One hundred and thirty seven women (60.9%) were not currently using 
condoms while 43 (19.1%) used condoms occasionally and 45 (20%) always used condoms 
during sexual intercourse. 
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Before sterilisation, most women had 1 sexual partner (n=209; 92.9%), with 9 women (4%) 
having 1-3 partners and 6 women (2.7%) with no partner. Women where asked about sexual 
partners before sterilisation and whether these were current or ever sexual partners was not 
obtained. 
 
Of the 225 women, 191 (84.9%) had no previous history of sexually transmitted infections.  
Thirty four patients (15.1%) reported a past history of vaginal discharge, vaginal ulcers, pelvic 
inflammatory disease or genital warts. Other past gynaecological problems reported by women 
were endometriosis (n=1; 0.4%) and polycystic ovary syndrome (n=1; 0.4%).  
 
Of the 225 women, 107 (47.6%) were amenorrhoeic due to injectable contraception, 80 
women (35.6 %) reported days of menses less than 4 days, 36 women (16%) reported days of 
menses between 4-8 days and 2 women (0.9%) reported menses greater than 8 days. Fifty 
three women (23.6%) reported light flow, 57 women (25.3%) reported average flow, 8 women 
(3.6%) reported heavy flow and 107 women were amenorrhoeic. Three women (1.3%) 
reported pain with menses not requiring medication.  
 
3.7 Reasons for sterilisation and intra-operative findings 
 
The primary reason that women in the study gave as the reason for requesting tubal ligation 
was that their families were complete. All procedures were successful.  
 
One laparoscopic procedure (0.4%) was converted to laparotomy due to difficulty of the 
procedure and suspected broad ligament bleed. This bleed resolved spontaneously and no 
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sutures were applied. This woman was morbidly obese with a BMI 42 with no prior surgical 
history. Intra-operative complications included cervical perforation with the Hulka 
manipulator (n=1; 0.4%) and uterine perforation with the Hulka manipulator (n=2; 0.8%). In 
one woman the cervix was torn with a uterine manipulator and was repaired. The two cases of 
uterine perforation were successfully managed conservatively.  
Other intraoperative findings included: 
- Adhesions from previous operations (n=9; 4%) – nil failures or complications noted 
from the tubal ligation procedure 
- Ovarian cysts – (n=5; 2.2%) – All women were referred to their base hospitals for  
further management 
- Unilateral hydrosalphinx – (n=2; 0.8%) 
- Incidental fibroids – (n=2; 0.8%) 
 
3.8 General health post sterilisation 
 
Of the 225 women, 169 women had tested HIV negative pre-sterilisation. Of these, 168 
women remained HIV negative. One woman who had tested HIV negative pre-sterilisation 
had tested positive post sterilisation.  She had complaints of recurrent vaginal discharge which 
made her seek attention at her clinic before her follow up date. Of note she had one sexual 
partner before sterilisation and two partners post sterilisation. Whether these sexual partners 
were two new partners or two simultaneous partners was not obtained. She had also noted an 
increase in sexual activity post sterilisation (once a week) as opposed to pre-sterilisation (once 
a week to once a month). Her repeat Pap smear was normal and repeat HIV test positive. She 
was aware of her status at follow up consultation. Among the study cohort, there was no 
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increase in new HIV infections post sterilisation (RR 0.006; 95 % CI (0.001-0.042); p=1). 
When stratified by race, the majority of HIV positive women were Black (n= 57; 98%) with 
the remaining woman being Coloured (n=1; 2%).  The risk of HIV acquisition among Black 
women did not reach statistical significant (p=1). 
 
Of the 56 women (25%) who were HIV positive, 38 (67.9%) were on anti-retroviral drugs 
(ARVs) and 18 (32.1%) were not on treatment due to CD4 counts >350. Of the 18 women 
who did not qualify for ARVs on the basis of high CD4 counts of >350 cells/μl pre-procedure, 
one patient had a drop in CD4 count post procedure (600 cells/μl to 341 cells/μl) requiring 
referral for ARVs. In women who were HIV positive, the mean CD4 count pre-procedure was 
425.5 cells/μland 600.9 cells/μlpost procedure. There was a significant rise in CD4 (p=0.02) 
with 67.9% of women being on anti-retroviral drug treatment. 
 












  Not on 
HAART 
(CD4 >350) 
On HAART    
Pre-sterilisation 169 18 (32.1%) 38 (67.9%) 425.5 276 66.8 




Of the 225 women who tested RPR negative pre-sterilisation, 224 women tested negative post 
procedure with one woman testing positive post procedure.  She was previously noted to be 
HIV negative and was asymptomatic for syphilis. Her formal titres and confirmatory 
Treponema pallidum haemagglutination assay (TPHA) were negative and she required no 
treatment. There was no statistical difference in RPR results pre and post procedure. 
 
3.9 Reproductive health post sterilisation 
 
Pap smears post sterilisation were performed on women who had not had a recent Pap smear 
(as per national screening program), women who had gynaecological symptoms and women 
who had abnormal or inadequate Pap smears pre-sterilisation. 
 
Of the 206 women with normal Pap smears pre-procedure, 26 (12.6%) repeat smears were 
normal. One hundred and seventy five (84.9%) women had no indication for a repeat smear 
and 4 women (1.9%) had LSIL on repeat Pap smears. Of these 4 women, 3 were HIV positive 
(75%) and 1 woman HIV negative (25%). Among women with LSIL on pre-sterilisation 
smears, 1 woman had HSIL on repeat smear and the other patient persistent LSIL. Both 
women were HIV positive and referred for colposcopy. Of the 12 women with no pre-
sterilisation Pap smear, 9 had repeat Pap smears which were normal (75%) and 3 had HSIL on 
repeat Pap smears (25%). All 3 of these women were HIV positive. The 1 woman with 
ASCUS on pre-sterilisation Pap smear had LSIL on repeat smear and was subsequently 
referred for colposcopy. She was HIV negative. Statistically, there was no change in Pap 




Table 5 : Pap smear pre and post sterilisation - Cross-tabulation 
 
 
Pap smear post sterilisation 




Not Done 5 4 0 3 0 12 
Normal 23 26 4 0 153 206 
LSIL 0 0 1 1 0 2 
HSIL 3 0 0 1 0 4 
ASCUS 0 0 1 0 0 1 
Total 31 30 6 5 153 225 
 
Of the 45 women who always used condoms pre-sterilisation, 42 (93.3%) continued to always 
use condoms, 1 woman (2.2%) used condoms occasionally and 2 (4.4%) stopped using 
condoms post procedure. Of those women who occasionally used condoms, 2 of the 43 
women reported stopping condom use post sterilisation (4.7%) with 39 women still 
occasionally using condoms (90.7%) and 2 always using condoms (4.7%). 
 
Of the total cohort of women, 62.7% did not use condoms post procedure (from 60.9% pre-
procedure), with only 37.3% of women using condoms either occasionally or always (Figure 






Figure 4: Condom use pre and post procedure 
 
 
Seven women reported no sexual partner pre-sterilisation. Five of these women reported 1 
partner post sterilisation and 2 reported no partners post sterilisation. Of women with 1 partner 
pre-sterilisation, 199 of the 209 reported still 1 partner with 4 reporting 1-3 partners post 
sterilisation and 6 women reporting no partner post sterilisation.  The 9 women with 1-3 
partners pre-sterilisation all reported just 1 partner post sterilisation. There was no statistically 



























Post sterilisation, 11 of the 225 women (4.9%) reported STIs. Ten women sought medical 
attention for vaginal discharges and 1 for genital warts. None of these women reported a 
history of PID post sterilisation. Of the 11 women with STIs post sterilisation, 6 women had 
previously sought medical attention for STIs pre-sterilisation (17.6%) and 5 women (2.6%) 
had no history of a prior STI.  There was a statistically significant increase in STIs post 
sterilisation in those women who had previous STIs (OR 6.7; 95% CI (2.2–20.9); p=0.002) 
compared to women who had no history of STIs pre-sterilisation. In women with no prior 
history of a STI, there was no significant risk of STIs post sterilisation (OR 0.8; 95% CI (0.7-
0.9); p=0.001) (Table 6, 7, 8). 
 
Table 6: STIs pre and post sterilisation 
 






























Yes Count 6 28 34 
%  17.6% 82.4% 100.0% 
No Count 5 186 191 
%  2.6% 97.4% 100.0% 
Total Count 11 214 225 
%  4.9% 95.1% 100.0% 
 
Table 8: Risk estimate for STIs post sterilisation 
 
OR for previous STI  95% Confidence Interval  
For cohort post = yes 6.741 2.179 20.855 
For cohort post = no 0.846 0.723 0.990 
N of Valid Cases 225   
 
 
When questioned on sexual activity post sterilisation, the majority of women (n=120; 53.3%) 
reported more than 1x weekly sexual intercourse with 94 women (41.8%) reporting sexual 
activity between 1x weekly to 1x month and 11 women (4.9%) reported not being sexually 
activity post procedure. When asked about sexual pleasure and interest post procedure, 58.7% 
reported same interest and pleasure compared to pre-procedure, 27.1% more interest and 








Among women with STIs post sterilisation, 6 (54.5%) women had a previous history of STIs 
pre-sterilisation. Of these 6 women, 4 (66.7%) were HIV negative and 2 (33.3%) were HIV 
positive. Among the HIV positive women, 1 woman (50%) reported an increase in partners 
post procedure. Both women reported condom use occasionally during sexual intercourse and 
not consistently. Both women reported an increase in sexual activity post sterilisation with the 
same sexual interest and pleasure as pre-sterilisation. The remaining 4 women who were HIV 
negative all reported no condom use post sterilisation. Two of these 4 women (50%) reported 
an increase in sexual partners post sterilisation. Three of the four women (75%) reported 
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increased sexual activity and pleasure post sterilisation and 1 woman (25%) reported the same 
sexual interest and pleasure. 
 
Of the 5 women (45.5%) who had no prior history of STIs pre-sterilisation, all were HIV 
negative. Four women (80%) reported 1 partner pre and post sterilisation and 1 (20%) 
reported 1 partner pre-sterilisation and 2 partners post sterilisation. None of these women 
reported condom use pre and post sterilisation. Four of these women reported more frequent 
sexual intercourse with the same interest and pleasure. One woman reported same frequency 
and sexual interest and pleasure as pre-sterilisation. 
 
Table 9 outlines menstrual patterns pre and post sterilisation controlling for previous 
contraceptive use. Women on barrier methods and those not on any contraceptive pre-
sterilisation had no statistically significant change in their days of menstrual bleeding or 
dysmenorrhoea (p=1 and p=0.89 respectively).  
 
Among the 107 women with amenorrhoea on injectable contraception pre-sterilisation, 73.8% 
(n=79) reported return to regular menses and 26.2% (n=28) reported abnormal uterine 
bleeding post sterilisation (prolonged menstrual bleeding, heavy menstrual bleeding and cycle 
irregularity). Among the 42 injectable contraceptive users with regular menses or spotting pre-
sterilisation, 71.4% (n=30) reported no change in menses post sterilisation and 28.6% (n=12) 




Among previous injectable users, there was a statistically significant increase in days of 
bleeding (p=0.03), amount of menstrual bleeding (p=0.01) and dysmenorrhoea post 
sterilisation (p=0.005).  Fourteen women (9.4%) sought medical attention post sterilisation for 
heavy menses (n=4; 28.6%) and cycle irregularity (n=10; 71.4%). These women were assessed 
clinically for abnormalities and 1 woman (7.1%) was found to have leiomyomas and referred 
to her base hospital for further treatment. The remaining women in whom no abnormalities 
were found were successfully treated medically.  
 
Among previous COC users, 37 women (71.2%) reported heavy or prolonged menses post 
sterilisation. Cycle irregularity was reported by 5 women (9.6%) and dysmenorrhoea by 33 
women (63.5%). There was a statistically significant increase in duration of menses (p=0.02), 
flow of menses (p=0.01) and dysmenorrhoea (p=0.001) post sterilisation. Five women (9.6%) 
sought medical attention post sterilisation for heavy menses and cycle irregularity. Clinically 













Table 9: Menstrual patterns pre and post tubal ligation controlling for contraceptive use 
 Contraceptive use pre-tubal ligation (TL) 
Parameter Injectable 
contraception 
n (%) = 149 (66.2) 
COC 
n (%) = 52 (23.1) 
Barrier 
n (%) = 11 (4.9) 
Nil 




Pre – TL Post – TL Pre – TL Post–TL Pre – TL Post –TL Pre – TL Post- TL 
Amenorrhoea 107 (71.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
< 4 days 27 (18.1) 79 (53.0) 38 (73.1) 4 (7.7) 7 (63.6) 7 (63.6) 8 (61.5) 69 (46.2) 
4 - 8 days 14 (9.4) 65 (43.6) 14 (26.9) 44 (84.6) 3 (27.3) 3 (27.3) 5 (38.5) 7 (53.8) 




        
Amenorrhoea 107 (71.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Light 21 (14.1) 46 (30.9) 24 (46.2) 2 (3.9) 4 (36.4) 4 (36.4) 4 (30.8) 3 (23.1) 
Average 18 (12.1) 76 (51.0) 28 (53.9) 27 (51.9) 5 (45.5) 4 (36.4) 6 (46.1) 7 (53.9) 




        
Amenorrhoea 107 (71.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Regular 32 (21.5) 130 (87.3) 52 (100) 47 (90.4) 10 (90.9) 10 (90.9) 13 (100) 13 (100) 




        




0 (0) 39 (26.2) 0 (0) 28 (53.9) 0 (0) 0 (0) 
 
 








3.10 Complications post sterilisation 
 
No pregnancy or pregnancy related events were noted in the study population during the given 
time period.  
 
One woman (0.4%) was readmitted a day post procedure for urinary retention. Investigations 
revealed a urinary tract infection which was successfully treated with a course of antibiotics.  
 
One woman (0.4%) reported port site hernia post procedure which required surgical treatment 




One woman (0.4%) sought medical attention for wound sepsis post procedure. This was 
successfully treated with dressings and antibiotics. 
 
Abnormal uterine bleeding was a common complaint expressed by women post procedure. 
Nineteen patients (8.4%) sought medical attention from their local clinics, general 
practitioners or regional hospitals for this complaint. None of the women required admission 
and 17 women were treated with a course of tranexamic acid with or without haematinics and 
2 women were treated with the combined oral contraceptive pill.  
 
Eleven women (4.9%) sought medical attention for a vaginal discharge post procedure. No 
women were admitted to hospital. Ten received syndromic treatment for a sexually transmitted 




Other complaints experienced post operatively by women included: 
- Four women (1.8%) reported pain over the port site relieved by simple analgesia 
(Paracetamol +/- Non Steroid Anti-inflammatory Drugs). 
- Pelvic pain (n=2; 0.9%). 1 woman was successfully treated with Non-Steroid Anti-
inflammatory Drugs (NSAIDs) and the other woman was being worked up for an 
organic cause. 
- One woman (0.4%) reported an offensive vaginal discharge and irregular menses post 
procedure. Examination revealed a cervical polyp which histology confirmed as 
benign. 
- One woman (0.4%) reported persistent lower backache post procedure. Examination 
revealed no organic cause for the complaint and she was successfully treated with 
simple analgesia. 
- Three women (1.3%) reported feelings of bloatedness post procedure 
- Two women (0.9%) reported ovarian cysts (1 diagnosed intra-operatively) and 1 
woman diagnosed post operatively due to abdominal distension. Both women were 
assessed their base hospitals for cystectomy. 
- Two women (0.9%) reported at least 5 kg weight gain post procedure. 
 
Regret was expressed by 2 women in the study population (0.8%). The first woman was 35 
year olds. She was married with 4 living children at the time of sterilisation. She subsequently 
divorced and remarried and regretted the procedure. She and her new husband wanted a child 
together.  The second woman was 33 years old with 2 children. She had divorced her husband 




Women were requested to rate their overall satisfaction of the procedure presented on a visual 
analogue scale. The rating of 1 being dissatisfied and 10 being very satisfied was used. The 
majority of women (n=132; 58.7%) were very satisfied with the procedure with women 
scoring the procedure 9 (n=52; 23.1%), 8 (n=25; 11.1%), 7 (n=9; 4%), 6 (n=2; 0.9%), 5 (n=5; 
2.2%). Of the women who were least satisfied with the procedure (those giving scores of 5 and 
6), the cited reasons were: 
- Heavy or prolonged menstrual bleeding post procedure (n=4) 
- Regret from the procedure due to remarriage (n=1) 
- Weight gain and bloatedness (n=1)  























In women who were HIV positive, the mean CD4 count pre-procedure was 425.5 cells/μl with 
the mean CD4 post procedure being 600.9 cells/μl. There was a significant rise in CD4 counts 
with 67.9% of women being on anti-retroviral drug treatment. When using the t-test the 
statistical significance was p=0.02. 
 
Eleven women (4.9%) reported sexually transmitted infections post sterilisation. STIs were 
found in 3 of the single women (27.3%) and in 8 of the married women (72.7%). As most 
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women in the study population were married (n=156), the incidence of STI in this population 
was 5 in 100 and in single women 4 in 100. There was a non-significant increased risk of STIs 
among married women versus single women (RR 1.2; 95% CI (0.3–4.3); p=0.8029).   
 
The association between condom use and marital status further adds value to the above 
mentioned. Thirty nine of 156 (25%) married women used condoms during sexual intercourse 
while 42 of 64 (65.6%) single women used condoms during sexual intercourse. This 
association did not however reach statistical significance. The likelihood of single women 
using condoms during sexual intercourse was significantly higher than married women 
(likelihood ratio 35.6; p=0.228). 
 
Further analysis of condom use post sterilisation revealed that the majority of HIV positive 
patients used condoms always during coitus post sterilisation (66.7%). The remaining 21.1% 
of HIV positive patients used condoms occasionally and 12.3% did not use condoms post 

















In this chapter, we address the six objectives and the purpose of the study as outlined in 
chapter two. The analysis of the data from the previous chapter is discussed and interpreted 
with reference to the literature review and similar research conducted locally and 
internationally. The discussion focuses on the reproductive health, women’s use of the health 
services and overall satisfaction following interval laparoscopic sterilisation of women at King 
Dinuzulu Hospital Complex in Durban, South Africa.  
 
Unintended pregnancy jeopardizes the lives and health of women and their families globally.  
The availability and accessibility of contraceptive services are key tools in the prevention of 
unintended pregnancy. Tubal ligation is an effective, safe and accessible contraceptive method 
and serves as an invaluable tool in trying to solve this global problem. 
 
In South Africa, female sterilisation accounts for up to 14% of contraceptive use among 
sexually active women (South African Demographic Health Survey, 2003). This procedure is 
offered free of charge to all women in the public health system. In Durban, South Africa, King 
Dinuzulu Hospital (formerly King George V Hospital) remains the primary referral center for 
interval laparoscopic sterilisation. 
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This study aimed to assess the reproductive health and patient satisfaction following interval 
sterilisation in Durban. The information gathered from this research will not only assist local 
health care providers to counsel their patients who choose sterilisation as their method of 
contraception better but also serves as an audit of current practice and allows for 
improvements in service delivery. The study has identified issues in reproductive health of 
women undergoing sterilisation and has attempted to recommend strategies to improve 
women’s reproductive health and satisfaction post sterilisation. In this research study, we have 
also compared our study findings with previous studies and publications and acknowledge that 
the findings of our study will contribute to current literature and promote further research in 
this field. 
 
4.2 Discussion and interpretation of the findings  
 
Objective 1: To determine the demographic profile of women having interval  
sterilisation at King Dinuzulu Hospital Complex. 
 
The majority of the study population consisted of Black women (60%) with the remaining 
women being Indian (35.6%), White (8%) and Coloured (2.7%).  This profile is similar to a 
previous retrospective study in the same setting with the study population of African women 
being greater than Asian women (67.56% compared to 32.44%) (Green-Thompson et al., 
1993).  The racial demographic profile of KwaZulu-Natal, as by the Census 2011 Municipal 
report KwaZulu-Natal, illustrated that the population of KwaZulu-Natal is predominately 
African/Black (86.9%) with the remaining groups representing the minority (Coloured: 1.3%, 
Indian: 7.5% and White: 4%) (Figure 7). 
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Our study population illustrates that the majority of our cohort was African/Black women 
however the figures illustrate an under-representation of this population group in comparison 
to population statistics in the province. 
 
Figure 7: Distribution of population by population group and district municipality - 
1996, 2001 and 2011. KwaZulu-Natal 
 
 
(Census 2011 Municipal report KwaZulu-Natal) 
 
This South African demographic profile differs from data from the United States of America 
with the population group in the CREST study being predominately white (65.8%) and just 
28.5 % of patients being of Black race (Costello et al., 2002). 
 
The mean age of women was 35 years. These results are similar to previous data in our setting 
with a mean age of 34.5 years in African women (Green-Thompson et al., 1993).This age is 
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moderately higher that the national median age of sterilisation which is 32 years of age in 
South Africa (South African Demographic Health Survey, 2003). This mean age of 
sterilisation appears higher compared to the CREST study which showed that 75% of women 
were 35 years or younger (Costello et al., 2002). Our study thus demonstrates that women are 
choosing sterilisation at an older age. Probable reasons would include career and delayed child 
bearing, accessibility to other contraceptive methods and adequate counselling of women pre- 
procedure to avoid regret in the further. Age less than 30 years at sterilisation is a single most 
important predictor of regret. Overall, the literature suggests that younger women are more 
likely to regret their decision and to request information about sterilisation reversal.  Up to 
20.3% of women aged 30 years or younger at the time of sterilisation regret their decision 
versus 5.9% of women older than 30 years (Curtis et al., 2006). In our study, 0.8 % of the 
study population expressed regret following sterilisation. The mean age of these women was 
34 years and reason for regret being a change in partners.  
 
The majority of women were married 69.3% versus 30.7% unmarried patients. The mean 
husband’s age was 39 years. All women were parous with the majority of women having at 
least 2 or more children (99.6%). The mean age of the youngest child was 3 years. Green-
Thompson et al (1993) found the mean parity of 2.96 and 5 (Asian and African women 
respectively) in this setting. Similarly, populations from the CREST study revealed the 
majority of women being married (63.9%) and having children (93.1%) (Costello et al., 2002). 
This illustrates that women who are in stable relationships with children may choose 





The mean BMI of women was 33.3 kg/m
2
 (obese). Obesity has been previously recognised as 
a risk factor for laparoscopy but there were no failed or unsuccessful procedures in this study 
group. One woman (0.4%) in the population group was morbidly obese and the laparoscopic 
procedure was converted to laparotomy due to difficulty of procedure and suspected broad 
ligament bleed. This study was based in a training hospital, with registrars performing the 
procedure under supervision. Although overall laparoscopy complications rates were low, data 
from our training facility may differ from international studies where laparoscopy is 
performed by consultant specialists. Literature suggests no differences in complications rates 
during laparoscopic tubal ligation among obese versus non obese women. Singh et al (1996) 
performed a retrospective analysis of interval laparoscopic tubal sterilisation in 147 obese 
women and compared their findings to 101 non-obese women. Their results revealed no 
overall differences in operating times or estimated blood loss, and no woman in either group 
had a complication. They showed that laparoscopic tubal sterilisation was safe in obese 
women. 
 
The majority of this study population received secondary and post-secondary education, 
however, only 46.7% were employed and 53.3% were unemployed. Most women were of low 
socio-economic status earning < R5000 a month (48.9%). This illustrates our population group 
having received formal education but not being employed with low socio-economic status. 
 
The majority of the study population was well with no significant co-morbidities (84.9%). Of 
the total population, 20.9% had previous abdominal surgical procedures. Among these 




Objective 2: To determine reasons women choose sterilisation as a contraceptive method  
 
A total of 337 women underwent tubal sterilisation at King Dinuzulu Hospital (formerly King 
George V Hospital) over a nine month period.  This is a substantial decrease in procedures 
conducted in the same setting from a case series between 1989 to 1991 (over 5360 procedures 
performed over this 3 year period) (Green-Thompson et al., 1993). This illustrates than women 
are choosing interval sterilisation less frequently than in the past with a 70% decline in its use 
from the previous case series. This may be the result of less contraceptive use by women in 
this setting, more availability and usage of other contraceptive methods or lack of referral of 
women for interval sterilisation.  
 
The majority of our cohort, 66.2% of the study population, was previously using injectable 
contraception at the time of sterilisation. This illustrates the popular use of injectable 
contraceptives in the country as evidenced by South African statistics of this method being 
used by up to 56% of sexually active women (South African Demographic Health Survey, 
2003). 
 
Of this study cohort, only 15.5% of women used dual contraception [barrier + oral 
contraception (2.2%) and barrier + injectable contraception (13.3%)] pre-sterilisation. Of 
particular importance is that 60.9% of women did not use condoms pre-procedure and 62.7% 
post procedure. This low rate of condom use is disappointing. As encouraged in the National 
Contraception Clinical Guidelines 2012 of South Africa, condom use post sterilisation should 
be emphasised by health professionals to women and they should be made aware that 
sterilisation offers no protection from HIV and STIs. 
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The principal reason for tubal ligation expressed by the women was that their families were 
complete.  
 
Objective 3: To assess overall satisfaction one year post sterilisation procedure 
 
The majority of women were highly satisfied with the sterilisation procedure (97%). The 
remaining women stated their dissatisfaction due to bleeding abnormalities, regret following 
the procedure, weight gain and surgical scar. 
 
This investigation clearly shows that the risk of complications following interval sterilisation 
is low. The results are similar to complication rates reported in the literature, these being less 
than 1% with interval timing (Bartz & Greenburg, 2008). Huber et al (2007) reported major 
complications in women undergoing laparoscopic sterilisation being up to 1.7%. All 
procedures in this study were successful with few minor complications noted. No anaesthetic 
related complications or direct injuries to surrounding structures were reported in this series.  
 
Only 0.4% (1 woman) required conversion to laparotomy due to bleeding.  Similarly, Green-
Thompson et al (1993) showed low immediate complications rates in their study in the same 
setting. They noted a rate of conversion to laparotomy for haemorrhage of 0.37 per 1000 
laparoscopies and the incidence of haemorrhage being 1.12 per 1000 laparoscopies. No organ 
or bowel injury was reported in this series. As our case series was much smaller than this 
series and over a narrower time frame, the rate of 4 in 1000 procedures is higher than the 
previously noted (0.37 per 1000 procedures).  Our data are, however, comparable with case 
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series from the United States of America as minor or major bleeding accounts for 0.6–1% of 
their cases (Bartz & Greenburg, 2008).  
 
The procedure which required conversion to laparotomy was performed on a morbidly obese 
woman. The procedure was converted to laparotomy due to difficulty of the procedure and 
suspected broad ligament bleed. Chi et al (1985) showed that the incidence of surgical 
difficulties, technical failure rates and surgical time is higher for obese women than for non-
obese women. However, none of their surgical difficulties or technical failures led to serious 
consequences. Literature has shown no overall differences in complication rates among obese 
versus non obese patients following laparoscopic sterilisation. This has been reported by Singh 
et al (1996). No differences in complications were noted between obese and non-obese 
women. 
 
In this research study, 3 women (1.3%) had uterine/cervical perforations during laparoscopy.  
In a previous case study at King Dinuzulu Hospital (formerly King George V Hospital), the 
rate of uterine perforation was at 0.37 per 1000 procedures, however, this case series included 
more women over a 3 year period (Green-Thompson et al., 1993). Mehta et al (1981) reported 
accidental uterine perforation of 1.96% during laparoscopic sterilisation of which all cases 
were managed conservatively.  The incidence of uterine perforations during gynaecological 
surgery is estimated at 1.6% with higher incidences reported during surgical termination of 
pregnancies and hysteroscopic procedures (Shakir & Diab, 2013). Perforations are uterine and 
cervical and may be surgical and surgeon dependent. As in this case series, perforations were 
as a result of a uterine manipulator (5mm in diameter) with no active bleeding noted. 
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Conservative management with antibiotics, observation and explanation was successfully used 
to treat these women.  
 
Other postoperative complaints included urinary tract infection, port site hernia and wound 
sepsis (incidence 0.4% each). This is comparable to reported incidence of infection of 1.12 per 
1000 laparoscopies (Green-Thompson et al., 1993). This confirms laparoscopic sterilisation to 
be safe with a low procedure related morbidity and mortality. Huber et al (2007) found an 
incidence of urinary tract infections of 0.04% and wound dehiscence of 0.01% following 
interval sterilisation with a total minor complication rate of 0.26%. 
 
A proportion of women also reported non-specific lower abdominal pain (1.8%) and weight 
gain post procedure (0.9%) Both somatic and psychosocial problems post sterilisation have 
been observed in previous studies (Hendrix et al., 1999; Lutala et al., 2011). While women 
may report some peace of mind post procedure due to the removal of fear of pregnancy, 
reports have confirmed other women experience a range of complications stemming from their 
perceived body image, psyche, surroundings, and their relationship with healthcare providers 
(Lutala et al., 2011). 
 
Consistent with previous studies (Costello et al., 2002; Cooper et al., 1982; Bean et al., 1980; 
Richards et al., 1991; Smith et al., 1994), the majority of the women reported no change in 
sexual interest and pleasure after interval tubal sterilisation (58%). Of those women who did 
report change, most women reported more sexual interest and pleasure than less sexual interest 
and pleasure (27.1% versus 14.2%; almost 2x likely). This is similar to findings of previous 
studies which support that women report positive change substantially more than negative 
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change post sterilisation (Costello et al., 2002; Cooper et al., 1982). This is contrary to 
findings of a Turkish study by Gulum et al (2010) and a Danish study by Kjer et al (1990), 
who demonstrated negative effects of sterilisation on sexual function. Our study cohort also 
reported regular sexual activity with the majority of women (53.3%) being frequently sexually 
active (> 1x week). This positive effect of sterilisation on sexual activity, interest and pleasure 
may be attributed to the removal of fear of pregnancy as well as removal of adverse side 
effects from previously used contraceptives.  
 
Objective 4: To determine the prevalence of and reasons for regret post sterilisation 
 
Regret rates following sterilisation vary from 0.1–50%. (Curtis et al., 2006; de Melo et al., 
2005; Bartz & Greenburg, 2008). This variation occurs from different geographic population 
groups, different countries, age categories and life circumstances of women as well as time 
periods between delivery and tubal ligation. Although women after tubal sterilisation may 
experience regret and feelings of sorrow, pain, affliction, hurt, dissatisfaction, and anxiety, 
some authors have considered “true regret” when women desire and request reversal of tubal 
sterilisation (de Melo et al., 2005). 
 
Literature has shown an association between regret after tubal sterilisation and the death of 
children, a new partner or marriage, changes in socioeconomic status or life circumstance, age 
at the time of sterilisation, lack of information on sterilisation, and the time sterilisation is 





Regret was expressed by 2 women in this study population (0.8%). The first woman was 35 
years old. She was married with 4 living children at the time of sterilisation. She subsequently 
divorced and remarried and regretted the procedure as she and her new husband wanted a 
child together.  The second woman was 33 years old with 2 children. She had divorced her 
husband post procedure. She had found a new partner post procedure and wished she could 
have a child with her new partner. Both women had new partners post sterilisation and desired 
children with their new partner. Neither of these women, however, requested sterilisation 
reversal.  
 
Over a narrow time frame, this rate of regret is lower than found in the literature which reports 
regret rates of up to 12.7% (Bartz & Greenburg, 2008). None of the women were less than  
30 years of age. This factor appears to be the strongest predictor of regret with regret being 
expressed by up to 20.3% of these women (Curtis et al., 2006). The research finding is 
supported by further literature which has shown that women who changed partners after tubal 
sterilisation experience regret by up to 40 times more compared to those who had not changed 
partners (Hardy et al., 1996; de Melo et al., 2005). 
 
This has implications for this study population as selection and counselling of women on the 
risk of regret is essential. Women in unstable relationships, divorced or single must be aware 





Objective 5. To determine whether sterilisation influences the prevalence of 
gynaecological disorders in women e.g. menstrual abnormalities, sexually transmitted 
infections and pelvic inflammatory disease 
 
The South African National Cervical Screening Programme states that every woman should be 
offered 3 Pap smears in her lifetime starting at age 30 years. These Pap smears are performed 
at 10 year intervals if normal and repeated if the smear is inadequate. However, women with 
any gynaecological complaint must have a Pap smear performed as part of their 
gynaecological examination irrespective of their screening history. This 10 year interval 
screening results in a reduction of 64-70% of cervical cancer. More frequent screening has 
been shown to have greater reductions in cervical cancer incidence with reduction of up to 
84% with 5-year intervals and 94% with 2-year interval screening. A major concern with 
cytology is a high false-negative rate of 15-30%. International screening programmes involve 
more frequent screening as a result of this dilemma. The United Kingdom policy offers 
screening every 3-5 years if normal and United States screening is 3 yearly if smears are 
normal (Adam et al., 2013). 
 
Concern exists with Pap smears and HIV positive women. It has been shown that abnormal 
smears are increased 10 fold in HIV positive women (Maiman, 1998). Progression and 
regression of Pap smear abnormalities have also been associated with the level of immune 
suppression and plasma viremia, as reflected by the CD4 count and HIV viral load (Massad et 
al., 2001; Schuman et al., 2003). It is recommended that women with HIV infection have more 
frequent screening with cervical cytology. This involves screening twice in the first year after 
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diagnosis of HIV and, if normal, annually thereafter (Centres for Disease Control and 
Prevention (CDC), 2009). 
 
In this study population, the majority of women had normal Pap smears pre-sterilisation 
procedure (91.6%). Among the remaining 8.4% of women; 0.9% had LSIL, 1.8% HSIL and 
0.4% ASCUS on Pap smear. Of the women with HSIL on Pap smear, 75% were HIV positive 
and 25% were HIV negative.  
 
Post procedure, of those women with normal Pap smears pre-procedure; 12.6% had normal 
repeat smears and 1.9% LSIL and 84.9% had no indication for a repeat smear at their one year 
follow up. This finding is comparably lower than demonstrated by Adam et al (2013) who 
showed the incidence of cytological abnormalities was 6.48% yearly in women with a 
previously normal Pap smear and 11.71% yearly in women with an inadequate smear result. 
They further showed that the incidence of HSILs was low (<0.5%) in the first 2 years after a 
normal or inadequate Pap smear, even in a setting with a high prevalence of cytological 
abnormalities.Of our cohort of women with LSIL, 75% were HIV positive and 25% HIV 
negative. Among women with LSIL on pre-sterilisation smears, 50% had HSIL on repeat 
smear and 50% persistent LSIL. Both groups of women were HIV positive and referred for 
colposcopy.  Denny et al (2010) demonstrated that 27.3 % of women referred for colposcopy 
had LSIL, and most of these women were HIV positive. They also demonstrated that 35% of 
women had LSIL on Pap smear at entry and 4% of them progressed to HSIL over a 36-month 
follow-up period. In our study, 50% of women with LSIL on pre-sterilisation smears had 
HSIL on repeat smear and were referred for colposcopy. 
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Of the women with no pre-sterilisation Pap smear, 75% had normal Pap smears and 25% 
HSIL (all were HIV positive). The one woman with ASCUS on pre-sterilisation Pap smear 
had LSIL on repeat smear and was subsequently referred for colposcopy. She was HIV 
negative.  
 
Overall the majority of the women with cytological abnormalities requiring colposcopy were 
HIV positive (75%). This is comparable to the study by Denny et al (2010) who found that up 
to 70.2% of women referred to colposcopy for HSIL were HIV positive. 
 
It can then be concluded from our research study that cervical cancer screening efforts must be 
scaled up for all HIV infected women with proper referral criteria for colposcopy as required. 
We also noted cervical abnormalities in HIV negative women. There was, however, no 
significant progression of these lesions during the time period. Hence screening and 
appropriate referral in both HIV positive and negative women is mandatory. 
 
Sexually transmitted infections (STIs) are infections spread by vaginal, oral or anal 
intercourse.  Most STIs are asymptomatic but carry a risk of transmission. Symptoms and 
signs include vaginal discharge, genital warts and pelvic pain. The causative agents include 
bacteria, viruses or parasites.  Bacterial infections include chlamydia, gonorrhoea, and 
syphilis. Viral STIs include genital herpes, HIV and genital warts. Parasitic STIs include 
trichomonas vaginalis.  STI diagnostic tests are easily available in the developed world, but in 
developing countries are often not available due to the lack of resources and funding 
(Morrison et al., 2009). In this study population, STIs were categorised by symptoms 
experienced by women including a vaginal discharge, genital ulcers, warts or pelvic 
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inflammatory disease. Due to the lack of diagnostic tests available, women in this 
investigation study cohort were treated syndromically according to their symptoms. 
 
An estimated 340 million new STIs occur annually worldwide. This STI burden falls 
disproportionately on developing countries. Therefore, a priority in developing countries is to 
reduce this burden and treat infection in order to reduce the long term sequelae of untreated 
infection. These sequelae include pelvic inflammatory disease, chronic pelvic pain, ectopic 
pregnancy and increased risk of HIV transmission and acquisition. The use of barrier 
contraception is paramount to prevent both STI and HIV risk (Morrison et al., 2009). 
 
In this study, it was found that the risk of STIs is not directly affected by interval tubal 
sterilisation but is rather a reflection of sexual behaviour prior to sterilisation. A history of a 
prior STI in women undergoing tubal sterilisation conferred a 6 times risk of a repeat STI after 
sterilisation compared to women with no history of infection. In this subset of women, 
condom nonuse post sterilisation, increase in sexual partners and sexual activity, interest and 
pleasure was found. There was no statistically significant risk of HIV acquisition post 
sterilisation however an increase in STIs and HIV risk behaviour was found in women with a 
past history of STIs. Similarly, low rates of condom use and increased risk of STIs in high risk 
groups post sterilisation is supported by previous literature (Pruitt et al., 2010; Armstrong et 
al., 1992). Similar to Pruitt et al (2010), women in our study cohort were unlikely to use 
condoms if they were HIV negative or reported being married or having only one sexual 
partner post sterilisation. Previous literature found that women with a past history of STIs are 
more likely to plan condom use post sterilisation (Sangi-Haghpeykar et al., 1998) which 
differs from our study findings. In women with a past history of STIs, interventions to increase 
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condom use post sterilisation are needed to reduce both the risk of subsequent infections and 
HIV.  Education of both women and partners and offering ample free supplies may alleviate 
this problem. Sweat et al (2012), found condom social marketing (condom branding, media-
based marketing campaign and targeted population based campaigns) may double the odds of 
condom use. This may be an effective strategy in high risk populations to advocate condom 
use and increase its usage. 
 
Reassuring findings from our study was that the majority of HIV positive women used 
condoms post sterilisation (66.7%) which may reflect women’s use of the health system and 
counselling at HIV clinics which needs to be emphasised more and extended to all health 
facilities for both HIV positive and negative women.  
 
In women with no prior history of STIs, we found no risk of infection post sterilisation. This 
was due to older age of women, monogamous faithful relationships, no change in partners post 
sterilisation and no change in condom use post sterilisation. Furthermore, consistent with 
previous studies (Costello et al., 2002), the majority of women reported no change in sexual 
interest and pleasure after interval tubal sterilisation (58%).  
 
In our study cohort, we found an increased risk of STIs post sterilisation in women who had 
previously sought medical attention for a STI pre-sterilisation and amongst married women. 
The association between condom use and marital status further adds value to the above 
statement. Thirty nine of 156 (25%) married women used condoms during sexual intercourse 
while 42 of 64 (65.6%) single women used condoms during sexual intercourse. The likelihood 
of single women using condoms during sexual intercourse was higher than married women 
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(likelihood ratio 35.56; p=0.228). The majority of HIV positive women always used condoms 
during coitus post sterilisation (66.7%). The remaining 21.1% of HIV positive women used 
condoms occasionally and 12.3% did not use condoms post sterilisation. Of these HIV 
positive women, 33% were married. 
 
Studies in developed settings have found low levels of understanding among patients on the 
symptoms and consequences of sexually transmitted infections. Condom use remains low 
within marriages (or between regular sex partners) in both developed and developing 
countries. This is despite the substantial STI /HIV risk within many primary relationships 
(Morrison et al., 2009).  
 
Data on the relationship between STIs, HIV and marital status appears to differ as Rehle et al 
(2007) demonstrated HIV positive patients were more likely to be single or widowed than 
being married. While Bogaerts et al (2001) demonstrated a high prevalence of STI and herpes 











In women not on hormonal contraception pre-sterilisation, we found no change in menstrual 
patterns post sterilisation. This is supported by Wilcox et al (1992), who found that menstrual 
abnormalities (dysmenorrhoea, heavy bleeding) are more common 5 years post sterilisation 
than within the first 2 years post procedure.  Menstrual abnormalities in our study cohort were 
significant in women previously using hormonal contraception. There was an increase in 
duration and amount of menstrual bleeding and dysmenorrhoea post sterilisation among 
previous COC users. Among previous injectable contraceptive users, abnormal uterine 
bleeding and dysmenorrhoea was found in our study cohort. Our study findings suggest that 
menstrual changes post sterilisation are due to recent discontinuation of hormonal 
contraception rather than the sterilisation procedure itself. Literature further supports that 
sterilisation has no direct influence on menstrual patterns (Harlow et al., 2002; Westhoff, 
2000; Rulin et al., 1993). Accounting for prior contraceptive use, changes in menses post 
sterilisation have been shown to result in the return of pre-contraceptive use characteristics 
including dysmenorrhoea, heavy menstrual flow and cycle irregularity (Westhoff, 2000).  
 
Previously, it has been shown that women utilising injectable contraception have re-
establishment of menstrual cycles up to 6-8 months following the last injection (Westhoff, 
2000). In our study group, women subjectively reported changes in menses due to prolonged 
amenorrhoea (women on injectable contraception) and due to previous COC use.  
 
Abnormal uterine bleeding was a common complaint expressed by women post procedure. 
Among our cohort, 8.4% sought medical attention from their local clinics, general 
practitioners or regional hospitals for this complaint. None of these women required admission 
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and all women were treated medically (tranexamic acid with or without haematinics or the 
combined oral contraceptive pill). 
 
Objective 6: To assess if women are at greater risk of HIV acquisition post tubal ligation 
 
To our knowledge, no study has previously observed if sterilisation influences the risk of HIV 
transmission and the impact on CD4 counts. This study demonstrated no significant risk of 
HIV acquisition post sterilisation.  The relative risk of HIV acquisition post sterilisation was 
0.006 (p=1). Although HIV acquisition was not affected by sterilisation in this short term 
follow up, risk behaviour was increased post sterilisation among women with a past history of 
STIs. Armstrong et al (1992) compared HIV risk behaviours of sterilised and non-sterilised 
women. They found that sterilised women were more sexually active and tended not to use 
condoms. In their study, only 12% of participants used condoms after sterilisation. They 
showed no statistical differences of HIV risk related to multiple sex partners or to prostitution. 
There was an improvement in condom use among sterilised women with their follow up and 
attendance of family clinics and gynaecological services. The increase in HIV risk behaviour 
in women with a past history of STIs in our study can be improved by identifying and 
screening these women for HIV and STIs post procedure and offering continued family 
service counselling and condom usage post sterilisation. 
 
The South African National HIV management guidelines of 2014 states that all adults should 
be offered HIV counselling and testing whenever an opportunity arises, and this should be 
repeated annually, depending on the risk of HIV.  
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The role of CD4 counts in managing patients who test HIV positive is: 
- At initial diagnosis and annually thereafter 
- To identify eligibility for Cotrimoxazole (CD4 <200 cells/μl) 
- To identify eligibility for Cryptoccocal antigen test screening (CD4 <100 cells/μl) 
(Department of Health, South Africa, 2014) 
 
CD4 counts are used for the monitoring of therapeutic response to ART. For most women on 
therapy, an adequate response is defined as an increase in CD4 count in the range of 50-150 
cells/μl during the first year of ART. Within the first 3 months of treatment, there is an 
accelerated rise in CD4 count with subsequent increases approximately 50 to 100 cells/μl per 
year (Kaufmann et al., 2003). In our study population, in women who were HIV positive, there 
was a statistically significant increase in CD4 count post procedure (pre-procedure mean of 
425.5 cells/μl to post procedure mean of 600.9 cells/μl; p=0.02). This reflects both the 
effectiveness of anti-retroviral drugs and possibly indirectly reflects the compliance of our 

















A prospective study was conducted to determine reproductive health, women’s use of the 
health services and overall satisfaction following interval laparoscopic sterilisation at King 
Dinuzulu Hospital Complex (formerly known as King George V Hospital), in the Province of 
KwaZulu-Natal, South Africa. The research questions/objectives provided direction to the 
investigation under study. The research study covered five logical chapters which 
systematically and methodologically presented the research design and its findings. The 
following summary of the chapters gives the reader an in-depth insight into the study: 
 
Chapter 1: Orientation and Literature Review 
The first chapter provides a background to the research study. It commences by focusing on 
the introductory background to the problem investigated by reviewing both international and 
local literature and related research conducted followed by the legislative frameworks on 







Chapter 2: Research Design and Methodology 
This chapter outlines the significance of the study. In other words the foundation of the study 
is laid out clearly. It highlights the purpose of the study, the research questions, the 
methodology and the statistical analysis. 
 
Chapter 3: Analysis of the data collected and the findings 
Chapter 3 provides a detailed analysis of data collected through various instruments such as 
questionnaires and documents. Both quantitative and qualitative research methods were 
employed in the study. Both figures and tables are designed to illustrate the research findings 
based on the data collected. The detailed interpretation and analysis are directly linked to the 
research questions and purpose of the study as encapsulated in chapter two.   
 
Chapter 4: Discussion and Interpretation of the findings 
In this chapter, the six objectives and the purpose of the study as outlined in chapter two are 
answered. In this chapter, the analysis of the data in the previous chapter are discussed and 
interpreted with reference to the literature review and the similar research conducted 
internationally. The discussion also focuses on the reproductive health, women’s use of the 
health services and overall satisfaction following interval laparoscopic sterilisation of women 
at King Dinuzulu Hospital Complex in Durban, South Africa. 
 
Chapter 5: Summary, Conclusion and Recommendations 
This final chapter highlights the important contribution of this study to the reproductive health 
of the women undergoing interval laparoscopic sterilisation. The chapter further outlines how 
the underpinning research questions, purpose and objectives of the study were addressed. 
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Secondly the chapter makes concluding remarks on the findings and their importance to the 
overall health services and welfare of women. The chapter concludes by making some 
recommendations which are intended to improve the quality of health services of women who 




Interval tubal sterilisation is a safe and effective procedure in Durban, South Africa. This 
study not only serves as an audit of current practise but will assist local health care providers 
to better counsel women who choose sterilisation as their method of contraception. This would 
allow improvements of service delivery.  
 
This study found a low rate of complications from interval laparoscopic sterilisation. This 
finding is relevant in counselling women who fear the operative procedure due to surgical 
risks. This would also serve as a key aspect in alleviating women’s concerns pre-procedure. 
The study also found that complications rates are similar in both obese and non-obese women. 
This serves as an important aspect of counselling women who are obese who may fear the 
procedure due to misconceptions of an increase in failure or complications from the procedure.  
 
The risk of STIs in women undergoing tubal ligation was increased only in those women with 
a past history of infection. These findings have highlighted the importance of identification of 
women with a past history of sexually transmitted infections to be counselled and screened for 
infection post procedure. These women need to be counselled on correct and consistent use of 
condoms post sterilisation. Education of both women and partner in condom use and the non-
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protection of sterilisation in acquisition of HIV and STIs is crucial. Social marketing may be 
an effective strategy in South Africa to advocate condom use and increase its usage. The 
increase in HIV risk behaviour in women with a past history of STIs may further be improved 
by offering continued family service counselling and increasing more frequent follow up for 
these women post sterilisation procedure. 
 
In women previously using hormonal contraception, menstrual abnormalities are more likely 
post sterilisation. These symptoms were successfully treated conservatively or medically with 
no serious consequences. This is important in counselling women pre-procedure, particularly 
those women on hormonal contraceptive methods. They should be made aware that menstrual 
changes will occur (similar to their pre-contraceptive patterns). They should also be reassured 
that symptoms are minor and often require minimal or no treatment at all. 
 
The rate of regret was low post sterilisation. Regret was only expressed by women who had a 
change of partners. Women in unstable relationships, divorced or single must be aware of the 













A substantial decline was noted in sterilisation procedures from a previous report in this 
setting.  Our study recommends health practitioners to offer extensive counselling to all 
women who present to contraceptive services about sterilisation as a contraceptive method. 
Furthermore, women should be empowered with the knowledge that sterilisation is not only a 
simple, accessible procedure but also carries a low risk of both morbidity and mortality and 
has minimal effect on general and reproductive health.  
 
Our study found an increased risk of STIs post sterilisation in those women with a previous 
history of STIs pre-sterilisation. These findings have highlighted the importance of 
identification of women with a past history of STIs to be counselled and screened for infection 
post procedure.  
 
A significant rate of Pap smear abnormalities in this study population was noted.  Thus, we 
recommend that cervical cancer screening efforts must be scaled up for all HIV infected 
women with proper referral for colposcopy as required. This research study also found 
cervical abnormalities in HIV negative women however there was no significant progression 
of these lesions during the time period. Hence screening and appropriate referral for both HIV 





Further research recommendations 
 
Further research on factors responsible for the decline in use of sterilisation in South Africa is 
needed. Further research on the effect of HIV on sterilisation and risk behaviour is needed. 
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APPENDIX 1: DATA SHEET: PRE-STERILISATION   Study no: 
           
Demographics 
Age    Parity            Abortions          No of living children 
Race (1= Black, 2= Indian, 3= White, 4= Coloured)  
BMI  Haemoglobin (g/dl)   
Marital Status (1=Single, 2= Married, 3= Divorced, 4=Widowed)     
Education 
(1=None, 2=Primary, 3=Secondary, 4=Postsecondary) 
Occupation (1= Employed, 2= Unemployed)       
Family income per month        
(1=<R5000, 2=R5-R10000, 3=>R10000) 
HIV Status (1= Negative, 2= Positive, 3= Unknown)  
If HIV positive CD 4 Count 
If HIV positive (1= On HAART, 2= Not on HAART) 
RPR (1=Positive, 2=Negative, 3=Unknown) 
If RPR positive (1=Treated, 2=Incompletely treated, 3=Untreated) 
Medical History 






Last Pap Smear      Date of last pap smear 
(1=Not done, 2=Normal, 3= LSIL, 4=HSIL, 5=pending)     
Current Contraception:        
(1=Oral contraception, 2=Injectable contraception, 3=Intrauterine device, 4=Barrier method, 














Duration of current contraception: 
(1= <2years, 2= 2-5years, 3= >5years) 
Use of contraceptive methods 
(1=Continuous, 2=Interrupted use) 
No of partners (1=0, 2=1, 3=1-3, 4=>3) 
Use of condoms (1= Yes always, 2= Yes sometimes, 3=No) 
Previous STIs (1=Yes, 2=No) 
Type of STI 
(1=Vaginal discharge, 2=PID, 3=Genital warts, 4=Genital ulcers)   
Menstrual Pattern before sterilisation: 
Days of bleeding (1=<4, 2= 4-8, 3= >8) 
Amount of bleeding        
(1= Light, 2=Average, 3=Heavy, 4=Very heavy)  
Pain with menses   
(1=None, 2=Pain not requiring medication, 3=Pain requiring medication)  
Cycles (1=Regular, 2= Irregular)  
Intermenstrual bleeding (1=No, 2=Yes)  
Known Gynaecological Problem before sterilisation and treatment sought: 
E.g. MFU, PID, Infertility etc. 
  




Reason for Sterilisation 
(1=Family complete, 2=Socio-economic, 3=Advice from health personal, 4=Advice from 










APPENDIX 2: DATA SHEET: POST STERILISATION Study no:  
          
HIV status post sterilisation (1=Negative, 2=Positive) 
RPR (1=Positive, 2=Negative, 3=Unknown) 
If RPR positive (1=Treated, 2=Incompletely treated, 3=Untreated) 
Pap smear result post sterilisation 
(1= Normal, 2=LSIL, 3=HSIL) 
Use of condoms post sterilisation 
(1=Yes always, 2=Yes sometimes, 3=No)  
No of partners (1=0, 2=1, 3=1-3, 4=>3) 
Sexual activity post sterilisation 
(1=>1x weekly, 2=1x week-1x month, 3=No) 
Sexual experience post sterilisation 
(1=More pleasure/interest, 2=Less pleasure/interest, 3=Same pleasure/interest) 
Menstrual Pattern after sterilisation: 
Days of bleeding (1=<4, 2= 4-8, 3= >8) 
Amount of bleeding        
(1= Light, 2=Average, 3=Heavy, 4=Very heavy)  
Pain with menses   
(1=None, 2=Pain not requiring medication, 3=Pain requiring medication)  
Cycles (1=Regular, 2= Irregular)  
Intermenstrual bleeding (1=No, 2=Yes)  
Changes after sterilisation      
Menses 
(1=Increase in amount or flow of bleeding, 2= Decrease in amount or flow of bleeding, 
3=Cycle irregularity, 4= Intermenstrual bleeding) 
Pain with menses 
(1= Increase in pain with menses, 2= Decrease in pain with menses, 3= No change) 
Patient presentation to doctor or clinic for any gynaecological 
complaints after sterilisation       
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(1= Abnormal uterine bleeding, 2= Vaginal discharge, 3= Pregnancy/pregnancy related 
complaints, 4= Other and state)  
  
Patient hospitalisation for any gynaecological    
complaints after sterilisation 
(1=Abnormal uterine bleeding, 2= Vaginal discharge, 3= Pelvic inflammatory disease, 4= 
Pregnancy/pregnancy related complaints, 4= Other and state) 
  
Treatment received at hospital     
(1=Antibiotics, 2=Hormonal treatment, 3= Hysterectomy, 4=Other and state) 
  
Patient’s wish for more children after sterilisation (1=Yes, 2=No) 
Expression of regret post sterilisation (1=Yes, 2=No) 
If yes, state reason: 
  
 
Overall satisfaction with TL procedure: 
(1=dissatisfied, 10=very satisfied) 
 











APPENDIX 3: INFORMED CONSENT TO WOMEN 
Good morning/Sawubona 
We are conducting research on reproductive health following sterilisation in Durban. Research 
is just the process to learn the answer to a question. In this study we want to learn how patients 
feel about the sterilisation procedure and if they have any gynaecological or personal problems 
one year after the procedure. We ask you to participate in the study in allowing us to use some 
of the information you have given us today to be used in the study. Your name will not be 
included in the study at any time and your information shared today will only entered by 
response not by your name.  We hope that the information you will give us will allow us to 
better understand patients’ experiences post sterilisation so that if many problems arise, 
measures can be put in place to improve them. Your participation in this research is voluntary, 
and you will not be penalized or lose benefits if you refuse to participate or decide to stop at 
any time. 
You may contact Dr Gaysheen Kistan at 0832934845 any time if you have questions about the 
research or if you are injured as a result of the research. You may contact the Biomedical 
Research Ethics Office on 031-260 4769 or 260 1074 or Email BREC@ukzn.ac.za if you 
have questions about your rights as a research participant. 
The research study, including the above information, has been described to me orally. I 
understand what my involvement in the study means and I voluntarily agree to participate. I 
have been given an opportunity to ask any questions that I might have about participation in 
the study. 
____________________      ____________________ 
Signature of Participant                            Date 
 
____________________   _____________________ 




APPENDIX 4: INFORMED CONSENT TO PARTICIPANTS – ZULU 
IMINININGWANE YAKHO YOKUBA INGXENYE YOCWANINGO  
 
Sawubona  
Senza ucwaningo mayelana nokuzalanisa kulandela ukuthenwa kwamagciwane amandla 
eThekwini. Lolu cwaningo indlela yokuthola izimpendulo kumibuzo ekhona. Kulesi sifundo 
sifuna ukuthola ukuthi iziguli zithini (umbono wazo) mayelana nezindlela zokuthenwa 
amagciwane amandla nokuthi zibakhona yini izinkinga zezifo zabesisazane emva konyaka. 
Siyakucela ukuba ube yingxenye yalesi sifundo usivumele sisebenzise ulwazi osinike lona 
namuhla kulesi sifundo (cwaningo). Igama lakho ngeke lidalulwe nanoma yinini kanti nolwazi 
osinike lona luzofakwa ngaphandle kwegama lakho. Sethemba ukuthi ulwazi ozosinika lona 
luzosenza sazi kangcono ukuthini iziguli zibhekana nani emva kokuthenwa kwamagciwane 
amadla, khona uma kwenzeka inkinga, kukhona izinyathelo ezingathathwa zokulungisa. 
Awuphoqiwe ukuthi ube yingxenye yalolu cwaningo, futhi ngeke wajeziswa noma uphucwe 
okungokwakho uma ngabe unquma ukuyeka nanoma ngasiphi isikhathi.  
Ungagxumana no Dr Gaysheen Kistan kulenombola 0832934845 nanoma ingasiphi isikhathi 
uma unemibuzo mayelana noma ulimele ngesikhathi socwaningo. Ungaxhumana nehhovisi le 
Biomedical Research Ethics kule nombolo 031 260 4769 noma 260 1074 noma nge email 
BREC@ukzn.ac.za uma ngabe unemibuzo mayelana nalolu cwaningo.  
Lesi sifundo socwaningo sinemininingwane yocwaningo engichazelwe yona. Ngikwazi kahle 
okumele ngikwenze kulolu ncwaningo futhi ngizinikele ngokuthanda. Nginikiwe ithuba 
lokubuza nanoma yimuphi umbuzo mayelana nalolu cwaningo.  
 
____________________  ____________________  
Signature of Participant  Date  
 
____________________  _____________________  





APPENDIX 5: INFORMATION SHEET 
To all participants 
 
Our study aims to assess who chooses sterilisation as a contraceptive and the reasons women 
choose sterilisation as a contraceptive. We are following up women after sterilisation to assess 
how they feel about the procedure and if they have any problems with the sterilisation 
procedure. We wish to also assess if women have any regret following the procedure as well 
as if they have gynaecological problems after the sterilisation procedure. We hope that with 
the information given to us, we can address problems with the procedure and better improve 
the sterilisation process. 
 


















Kubo bonke abayingxenye yalolu cwaningo  
Isifundo sethu sihlose ukuhlola ukuthi obani abakhetha ukusebenzisa ukuthenwa 
kwamagciwane amandla njengedlala yokuvimbela ukukhulelwa nokuthi yiziphi izizathu 
abesifazane abanazo lokukhetha lendlela yokuyimbela ukukhulelwa. Siyabalandelela 
abesifazane abesifazane abasebenzisa lendlela yokuvimbela ukukhulelwa. Siyafisa futhi 
ukuhlola ukuthi ingabe abesifazane bayazisola ngokusebenzisa lendlela nokuthi babanazo yini 
izinkinga zezifo eziphathelene nabesifazane ngemuva kokusebenzisa lendlela.  
Siyathemba ukuthi ngolwazi osinike lona, singakwazi futhi sithuthukise indlela yokuthena 
amagciwane amandla.  











APPENDIX 7: PERMISSION TO KING DINUZULU HOSPITAL COMPLEX (KING 
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